FDA letter monthly archive

FDA Letters Issued in January 2021

Name: FDA Letters Issued in January 2021
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in January 2021. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Azurity Pharmaceuticals, Inc. (Jan 28, 2021)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Chemistry, manufacturing, and controls, Device constituent and human factors, Bioequivalence and pharmacokinetics. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedJan 28, 2021
US FDA• KONVOMEP

Complete Response Letter Azurity Pharmaceuticals, Inc. (Jan 28, 2021)